CVS Health's turnaround efforts in focus amid record-high medical costs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
CVS Health (CVS) PT Raised to $76 at Truist Securities
February 13, 2025 6:04 AM ESTTruist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $76.00 (from $60.00) while maintaining a Buy rating.
The analyst comments "We remain bullish on CVS post 4Q marked by top and bottom-line beats while 25 guidance provides an attractive baseline.... More
